Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10542 in Adult Paroxysmal Nocturnal Hemoglobinuria (Phase Ib/II, China)
CTR20260290Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10542 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Hengrui Therapeutics. Started Feb 2026; status: active.
02
Drugs
HS-10542
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on CTR20260290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260290.